Yunxuetang, an online corporate training services provider focused on China, has raised $100 million in Series D funding led by Centurium Capital. Existing investors Yunfeng Capital and SIG both re-upped.
The company claims to be the best-funded start-up in China's corporate training space, having raised $200 million across six rounds. In 2018, Yunfeng led a $50 million Series C round. This followed a $22...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.